Status | Study |
Not yet recruiting |
Study Name: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants Condition: Epidemic Parotitis,Mumps Date: 2017-04-17 Interventions: Biological: ≥3.0 lgCCID50/mlbut <3.5lgCCID50/ml Live Attenuated |
Not yet recruiting |
Study Name: Gender and Opioid Consumption Condition: Postoperative; Parotitis Date: 2016-12-27 Interventions: Drug: postoperative morphine Postoperatively, A loading dose of morphine will be given in incremental do |
Recruiting |
Study Name: SPI-directed Analgesia for Vitreoretinal Surgeries Condition: Vitreoretinal Surgeries Postoperative Nausea and Vomiting Date: 2016-11-22 Interventions: Drug: Metamizol in group A pat |
Recruiting |
Study Name: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine Condition: Encephalitis, Japanese Measles Mumps Date: 2016-08-17 Interventions: Biological: CD-JEV Single 0.5 |
Active, not recruiting |
Study Name: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants Condition: Mumps Date: 2016-02-23 Interventions: Biological: investigational live attenuated mumps vaccine |
Completed |
Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condition: Measles; Mumps; Rubella Date: 2014-07-03 Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209 |
Completed |
Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Condition: Rubella Mumps Measles Date: 2014-02-06 Interventions: Biological: Priorix® 1 do |
Completed |
Study Name: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. Condition: Measles Mumps Rubella Va Date: 2013-11-08 Interventions: Biological: MMR Bio-Manguinhos |
Completed |
Study Name: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) Condition: Mumps Rubella Measles Date: 2013-06-07 Interventions: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella) |
Completed |
Study Name: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Condition: Measles Mumps Rubella Date: 2013-01-21 Interventions: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin |